ImmunoGen (IMGN) Announces Common Offering
Tweet Send to a FriendGet Alerts IMGN Hot Sheet
Down)
Trade IMGN Now!
ImmunoGen, Inc. (Nasdaq: IMGN) announced today that it intends to offer for sale its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Morgan Stanley & Co. LLC and Jefferies & Company, Inc. are acting as joint book-running managers for the proposed offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Morgan Stanley & Co. LLC and Jefferies & Company, Inc. are acting as joint book-running managers for the proposed offering.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Lucas Energy (LEI) Files $10M Mixed Shelf
- Goldman Comments on Tesla Motors (TSLA) Equity and Convertible Debt Issue
- Cubic (CUB) Prices 2.32M Common Secondary Offering
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Morgan Stanley, Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
